[18F]2-fluoro-2-deoxyglucose positron emission tomography/ computed tomography in predicting radiation pneumonitis

Chinese Medical Journal

Volumn 122, Issue 11, 2009, Pages 1311-1315

  Song, Hao ^a   Yu, Jin Ming ^b   Kong, Feng Ming ^c   Lu, Jie ^b   Bai, Tong ^b   Ma, Li ^b   Fu, Zheng ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

18F 2 fluoro 2 deoxyglucose; Positron emission tomography; Radiation pneumonitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; LUNG CANCER; MALE; MORBIDITY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RADIATION DOSE; RADIATION PNEUMONIA; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIATION PNEUMONITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68249141224     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.11.014     Document Type: Article

References (21)

1. Kong FM, Haken RT, Eisbruch A, Lawrence TS. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin Oncol 2005; 32: 42-54.
2. Komaki R, Cox JD, Hartz AJ, Byhardt RW, Perez-Tamayo C, Clowry L, et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol 1985; 8: 362-370.
3. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327: 1618-1624.
4. Vujaskovic Z, Marks LB, Anscher MS. The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin Radiat Oncol 2000; 10: 296-307.
5. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003; 55: 110-115.
6. Wang XL, Yin JL, Li H, Li XD, Quan JT. PET/CT imaging of delayed radiation encephalopathy following radiotherapy for nasopharyngeal carcinoma. Chin Med J 2007; 120: 474-478.
7. Nestle U, Hellwig D, Fleckenstein J, Walter K, Ukena D, Rübe C, et al. Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients. Front Radiat Ther Oncol 2002; 37: 26-33.
8. Guerrero T, Johnson V, Hart J, Pan T, Khan M, Luo D, et al. Radiation pneumonitis: Local dose versus [(18)F]-fluorodeoxy glucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys 2007; 68: 1030-1035.
9. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002; 32: 293-321.
10. Wollmer P, Rhodes CG. Positron emission tomography in pulmonary edema. J Thorac Imaging 1988; 3: 44-50.
11. Hassaballa HA, Cohen ES, Khan AJ, Ali A, Bonomi P, Rubin DB. Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy. Chest 2005; 128; 1448-1452.
12. Groover TA, Christie AC, Merritt EA. Observations on the use of the copper filter in the roentgen treatment of deep-seated malignancies. South Med J 1922; 15: 440-444.
13. Trott KR, Herrmann T, Kasper M. Target cell in radiation pneumopathy. Int J Radiat Oncol Biol Phys 2004; 58: 463-469.
14. Kasper M, Haroske G. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 1996; 11: 463-483.
15. Rosiello RA, Merrill WW. Radiation-induced lung injury. Clin Chest Med 1990; 11: 65-71.
16. Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley MT, Bentel G, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998; 42: 1-9.
17. Oetzel D, Schraube P, Hensley F, Sroka-Pérez G, Menke M, Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995; 33: 455-460.
18. Hernando ML, Marks LB, Bentel GC, Zhou SM, Hollis D, Das SK, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001; 51: 650-659.
19. Allen AM, Henning GT, Ten Haken RK, Hayman JA, Martel MK. Do dose-volume metrics predict pulmonary function changes in lung irradiation? Int J Radiat Oncol Biol Phys 2003; 55: 921-929.
20. Marks LB, Munley MT, Bentel GC, Zhou SM, Hollis D, Scarfone C, et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997; 39: 563-570.
21. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323-329.